These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32447342)

  • 1. LncRNA SNHG17 aggravated prostate cancer progression through regulating its homolog SNORA71B via a positive feedback loop.
    Wu G; Hao C; Qi X; Nie J; Zhou W; Huang J; He Q
    Cell Death Dis; 2020 May; 11(5):393. PubMed ID: 32447342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SNHG17 promotes colorectal tumorigenesis and metastasis via regulating Trim23-PES1 axis and miR-339-5p-FOSL2-SNHG17 positive feedback loop.
    Bian Z; Zhou M; Cui K; Yang F; Cao Y; Sun S; Liu B; Gong L; Li J; Wang X; Li C; Yao S; Yin Y; Huang S; Fei B; Huang Z
    J Exp Clin Cancer Res; 2021 Nov; 40(1):360. PubMed ID: 34782005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SNHG17 upregulates WLS expression to accelerate lung adenocarcinoma progression by sponging miR-485-5p.
    Li W; Zheng Y; Mao B; Wang F; Zhong Y; Cheng D
    Biochem Biophys Res Commun; 2020 Dec; 533(4):1435-1441. PubMed ID: 33109341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer.
    Xu W; Chang J; Du X; Hou J
    Biomed Pharmacother; 2017 Nov; 95():1112-1118. PubMed ID: 28922730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative Analysis and Experimental Validation Indicated That SNHG17 Is a Prognostic Marker in Prostate Cancer and a Modulator of the Tumor Microenvironment via a Competitive Endogenous RNA Regulatory Network.
    Li J; Yu H; Yao J; Jiang Z; Li Z; Cui X
    Oxid Med Cell Longev; 2022; 2022():1747604. PubMed ID: 35864871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA SNHG17 contributes to the progression of pancreatic adenocarcinoma by modulating miR-32-5p/EZH2/STAT3 signaling.
    Ying L; Wang J; Feng J; Wu Z
    Mol Biol Rep; 2023 Jul; 50(7):5941-5947. PubMed ID: 37253918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway.
    Gao H; Liu R; Sun X
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8000-8010. PubMed ID: 31599425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA ADPGK-AS1 promotes pancreatic cancer progression through activating ZEB1-mediated epithelial-mesenchymal transition.
    Song S; Yu W; Lin S; Zhang M; Wang T; Guo S; Wang H
    Cancer Biol Ther; 2018 Jul; 19(7):573-583. PubMed ID: 29667486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silencing of lncRNA SNHG17 inhibits the tumorigenesis of epithelial ovarian cancer through regulation of miR-485-5p/AKT1 axis.
    Wang W; Yu S; Li W; Hu H; Zou G
    Biochem Biophys Res Commun; 2022 Dec; 637():117-126. PubMed ID: 36399797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA SNHG17 promotes tumor progression and predicts poor survival in human renal cell carcinoma via sponging miR-328-3p.
    Wu J; Dong G; Liu T; Zhang S; Sun L; Liang W
    Aging (Albany NY); 2021 Sep; 13(17):21232-21250. PubMed ID: 34497156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA SNHG17 promotes gastric cancer progression by epigenetically silencing of p15 and p57.
    Zhang G; Xu Y; Wang S; Gong Z; Zou C; Zhang H; Ma G; Zhang W; Jiang P
    J Cell Physiol; 2019 Apr; 234(4):5163-5174. PubMed ID: 30256413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNORA71B promotes breast cancer cells across blood-brain barrier by inducing epithelial-mesenchymal transition.
    Duan S; Luo X; Zeng H; Zhan X; Yuan C
    Breast Cancer; 2020 Nov; 27(6):1072-1081. PubMed ID: 32458152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA SNHG17 is an unfavourable prognostic factor and promotes cell proliferation by epigenetically silencing P57 in colorectal cancer.
    Ma Z; Gu S; Song M; Yan C; Hui B; Ji H; Wang J; Zhang J; Wang K; Zhao Q
    Mol Biosyst; 2017 Oct; 13(11):2350-2361. PubMed ID: 28933484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SNHG17 drives malignant behaviors in astrocytoma by targeting miR-876-5p/ERLIN2 axis.
    Du F; Hou Q
    BMC Cancer; 2020 Sep; 20(1):839. PubMed ID: 32883232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SP1-mediated upregulation of lncRNA SNHG4 functions as a ceRNA for miR-377 to facilitate prostate cancer progression through regulation of ZIC5.
    Wang ZY; Duan Y; Wang P
    J Cell Physiol; 2020 Apr; 235(4):3916-3927. PubMed ID: 31608997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long non-coding RNA SNHG17 may function as a competitive endogenous RNA in diffuse large B-cell lymphoma progression by sponging miR-34a-5p.
    Lu S; Zeng L; Mo G; Lei D; Li Y; Ou G; Wu H; Sun J; Rong C; He S; Zhong D; Ke Q; Zhang Q; Tan X; Cen H; Xie X; Liao C
    PLoS One; 2023; 18(11):e0294729. PubMed ID: 37988356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNHG17 Serves as an Oncogenic lncRNA by Regulating the miR-361-3p/STC2 Axis in Rectal Cancer.
    Huang F; Li H; Qin Z; Wang A; Zhang Y; Guo J; Wei M; Guo H; Pu J
    Front Genet; 2021; 12():654686. PubMed ID: 34249085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p.
    Lu W; Zhang H; Niu Y; Wu Y; Sun W; Li H; Kong J; Ding K; Shen HM; Wu H; Xia D; Wu Y
    Mol Cancer; 2017 Jul; 16(1):118. PubMed ID: 28697764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long non-coding RNA MYU promotes prostate cancer proliferation by mediating the miR-184/c-Myc axis.
    Wang J; Yang X; Li R; Wang L; Gu Y; Zhao Y; Huang KH; Cheng T; Yuan Y; Gao S
    Oncol Rep; 2018 Nov; 40(5):2814-2825. PubMed ID: 30132573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TERF1 downregulation promotes the migration and invasion of the PC3 prostate cancer cell line as a target of miR‑155.
    Chen W; He LN; Liang Y; Zeng X; Wu CP; Su MQ; Cheng Y; Liu JH
    Mol Med Rep; 2020 Dec; 22(6):5209-5218. PubMed ID: 33174061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.